MovDisordV3, Main, Exploration, bibRecord, 004074

Health‐related quality of life in patients with progressive supranuclear palsy

Identifieur interne : 004074 ( Main/Exploration ); précédent : 004073; suivant : 004075

Health‐related quality of life in patients with progressive supranuclear palsy

Auteurs : Anette Schrag [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Jennifer Davis [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Marjan Jahanshahi [Royaume-Uni] ; Niall Quinn [Royaume-Uni]

Source :

Movement Disorders [ 0885-3185 ] ; 2003-12.

RBID : ISTEX:F66F0F1908AC4335C9B79FEFC69F2FB97D838FEA

Descripteurs français

Pascal (Inist)
- Echelle évaluation, Evolution, Homme, Méthode mesure, Ophtalmoplégie supranucléaire, Psychométrie, Qualité vie, Questionnaire.
Wicri :
- topic : Homme.

English descriptors

KwdEn :
- Aged, Cognition Disorders (diagnosis), Cognition Disorders (etiology), Demography, Depressive Disorder, Major (diagnosis), Depressive Disorder, Major (etiology), EQ‐5D, Evaluation scale, Evolution, Female, Frontal Lobe (physiopathology), Health Status, Human, Humans, Male, Measurement method, Neuropsychological Tests, PDQ‐39, Psychometrics, Quality of Life, Quality of life, Questionnaire, Questionnaires, Supranuclear Palsy, Progressive (complications), Supranuclear Palsy, Progressive (diagnosis), Supranuclear Palsy, Progressive (physiopathology), Supranuclear ophthalmoplegia, carer, progressive supranuclear palsy, quality of life.
MESH :
- complications : Supranuclear Palsy, Progressive.
- diagnosis : Cognition Disorders, Depressive Disorder, Major, Supranuclear Palsy, Progressive.
- etiology : Cognition Disorders, Depressive Disorder, Major.
- physiopathology : Frontal Lobe, Supranuclear Palsy, Progressive.
- Aged, Demography, Female, Health Status, Humans, Male, Neuropsychological Tests, Quality of Life, Questionnaires.

Abstract

We assessed health‐related quality of life (QoL) of patients with progressive supranuclear palsy (PSP), identified the most important QoL issues in patients with this disorder, and assessed the usefulness of existing QoL measures in patients with PSP. Twenty‐seven patients in all stages of PSP and their carers underwent a semistructured in‐depth interview on the impact of PSP and a neurological examination. They were also asked to complete existing measures of QoL and depression. An item‐pool of issues relevant to QoL of patients with PSP was created from the patient and carer interviews. Carers and patients largely agreed on issues relevant for patients' QoL but more carers than patients considered symptoms of frontal lobe dysfunction as problematic for the patients. There was no association of QoL with age and gender, as assessed in interviews and on two QoL instruments. QoL deteriorated with increasing disease duration and severity and greater cognitive impairment and was associated with worse depression scores. While the generic SF‐36 was not found to be useful to assess QoL in PSP, feasibility and validity for the PDQ‐39 and the EQ‐5D were acceptable in this study. However, additional issues relevant to patients with PSP that were not addressed in these instruments included visual disturbances, dysarthria, dysphagia, muddled thinking, confusion, and apathy. The generic EQ‐5D and the Parkinson's disease‐specific PDQ‐39 are useful instruments to assess QoL in patients with PSP. However, they lack questions on important aspects of QoL in PSP that were reported by patients and carers in semistructured interviews. The item pool created in these interviews provides the basis for the development of disease‐specific QoL instruments for patients with PSP. © 2003 Movement Disorder Society

Url:

https://api.istex.fr/document/F66F0F1908AC4335C9B79FEFC69F2FB97D838FEA/fulltext/pdf

DOI: 10.1002/mds.10583

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Health‐related quality of life in patients with progressive supranuclear palsy</title>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</author>
<author><name sortKey="Selai, Caroline" sort="Selai, Caroline" uniqKey="Selai C" first="Caroline" last="Selai">Caroline Selai</name>
</author>
<author><name sortKey="Davis, Jennifer" sort="Davis, Jennifer" uniqKey="Davis J" first="Jennifer" last="Davis">Jennifer Davis</name>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation><country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
<author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F66F0F1908AC4335C9B79FEFC69F2FB97D838FEA</idno>
<date when="2003" year="2003">2003</date>
<idno type="doi">10.1002/mds.10583</idno>
<idno type="url">https://api.istex.fr/document/F66F0F1908AC4335C9B79FEFC69F2FB97D838FEA/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000D09</idno>
<idno type="wicri:Area/Istex/Curation">000D09</idno>
<idno type="wicri:Area/Istex/Checkpoint">002A04</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Schrag A:health:related:quality</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14673883</idno>
<idno type="wicri:Area/PubMed/Corpus">003605</idno>
<idno type="wicri:Area/PubMed/Curation">003605</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003765</idno>
<idno type="wicri:Area/Ncbi/Merge">000C59</idno>
<idno type="wicri:Area/Ncbi/Curation">000C59</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000C59</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Schrag A:health:related:quality</idno>
<idno type="wicri:Area/Main/Merge">005C97</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:04-0129347</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">002327</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000994</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">002439</idno>
<idno type="wicri:doubleKey">0885-3185:2003:Schrag A:health:related:quality</idno>
<idno type="wicri:Area/Main/Merge">005F85</idno>
<idno type="wicri:Area/Main/Curation">004074</idno>
<idno type="wicri:Area/Main/Exploration">004074</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Health‐related quality of life in patients with progressive supranuclear palsy</title>
<author><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Selai, Caroline" sort="Selai, Caroline" uniqKey="Selai C" first="Caroline" last="Selai">Caroline Selai</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davis, Jennifer" sort="Davis, Jennifer" uniqKey="Davis J" first="Jennifer" last="Davis">Jennifer Davis</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName>National Hospital for Neurology and Neurosurgery</orgName>
</affiliation>
</author>
<author><name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, London</wicri:regionArea>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2003-12">2003-12</date>
<biblScope unit="vol">18</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="1464">1464</biblScope>
<biblScope unit="page" to="1469">1469</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F66F0F1908AC4335C9B79FEFC69F2FB97D838FEA</idno>
<idno type="DOI">10.1002/mds.10583</idno>
<idno type="ArticleID">MDS10583</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Cognition Disorders (diagnosis)</term>
<term>Cognition Disorders (etiology)</term>
<term>Demography</term>
<term>Depressive Disorder, Major (diagnosis)</term>
<term>Depressive Disorder, Major (etiology)</term>
<term>EQ‐5D</term>
<term>Evaluation scale</term>
<term>Evolution</term>
<term>Female</term>
<term>Frontal Lobe (physiopathology)</term>
<term>Health Status</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Measurement method</term>
<term>Neuropsychological Tests</term>
<term>PDQ‐39</term>
<term>Psychometrics</term>
<term>Quality of Life</term>
<term>Quality of life</term>
<term>Questionnaire</term>
<term>Questionnaires</term>
<term>Supranuclear Palsy, Progressive (complications)</term>
<term>Supranuclear Palsy, Progressive (diagnosis)</term>
<term>Supranuclear Palsy, Progressive (physiopathology)</term>
<term>Supranuclear ophthalmoplegia</term>
<term>carer</term>
<term>progressive supranuclear palsy</term>
<term>quality of life</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term>
<term>Depressive Disorder, Major</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Cognition Disorders</term>
<term>Depressive Disorder, Major</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Frontal Lobe</term>
<term>Supranuclear Palsy, Progressive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Demography</term>
<term>Female</term>
<term>Health Status</term>
<term>Humans</term>
<term>Male</term>
<term>Neuropsychological Tests</term>
<term>Quality of Life</term>
<term>Questionnaires</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Echelle évaluation</term>
<term>Evolution</term>
<term>Homme</term>
<term>Méthode mesure</term>
<term>Ophtalmoplégie supranucléaire</term>
<term>Psychométrie</term>
<term>Qualité vie</term>
<term>Questionnaire</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We assessed health‐related quality of life (QoL) of patients with progressive supranuclear palsy (PSP), identified the most important QoL issues in patients with this disorder, and assessed the usefulness of existing QoL measures in patients with PSP. Twenty‐seven patients in all stages of PSP and their carers underwent a semistructured in‐depth interview on the impact of PSP and a neurological examination. They were also asked to complete existing measures of QoL and depression. An item‐pool of issues relevant to QoL of patients with PSP was created from the patient and carer interviews. Carers and patients largely agreed on issues relevant for patients' QoL but more carers than patients considered symptoms of frontal lobe dysfunction as problematic for the patients. There was no association of QoL with age and gender, as assessed in interviews and on two QoL instruments. QoL deteriorated with increasing disease duration and severity and greater cognitive impairment and was associated with worse depression scores. While the generic SF‐36 was not found to be useful to assess QoL in PSP, feasibility and validity for the PDQ‐39 and the EQ‐5D were acceptable in this study. However, additional issues relevant to patients with PSP that were not addressed in these instruments included visual disturbances, dysarthria, dysphagia, muddled thinking, confusion, and apathy. The generic EQ‐5D and the Parkinson's disease‐specific PDQ‐39 are useful instruments to assess QoL in patients with PSP. However, they lack questions on important aspects of QoL in PSP that were reported by patients and carers in semistructured interviews. The item pool created in these interviews provides the basis for the development of disease‐specific QoL instruments for patients with PSP. © 2003 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Londres</li>
</region>
<settlement><li>Londres</li>
</settlement>
<orgName><li>National Hospital for Neurology and Neurosurgery</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Schrag, Anette" sort="Schrag, Anette" uniqKey="Schrag A" first="Anette" last="Schrag">Anette Schrag</name>
</region>
<name sortKey="Davis, Jennifer" sort="Davis, Jennifer" uniqKey="Davis J" first="Jennifer" last="Davis">Jennifer Davis</name>
<name sortKey="Jahanshahi, Marjan" sort="Jahanshahi, Marjan" uniqKey="Jahanshahi M" first="Marjan" last="Jahanshahi">Marjan Jahanshahi</name>
<name sortKey="Lees, Andrew J" sort="Lees, Andrew J" uniqKey="Lees A" first="Andrew J." last="Lees">Andrew Lees (neurologue)</name>
<name sortKey="Quinn, Niall" sort="Quinn, Niall" uniqKey="Quinn N" first="Niall" last="Quinn">Niall Quinn</name>
<name sortKey="Selai, Caroline" sort="Selai, Caroline" uniqKey="Selai C" first="Caroline" last="Selai">Caroline Selai</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004074 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004074 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F66F0F1908AC4335C9B79FEFC69F2FB97D838FEA
   |texte=   Health‐related quality of life in patients with progressive supranuclear palsy
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Health‐related quality of life in patients with progressive supranuclear palsy

Health‐related quality of life in patients with progressive supranuclear palsy

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.